5:46 PM
 | 
Aug 31, 2009
 |  BC Extra  |  Company News

PhotoCure's Hexvix gets Priority Review

FDA accepted for filing and granted Priority Review to an NDA from PhotoCure ASA (OSE:PHO)...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >